Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Health insurance giant Aetna, which is owned by CVS Health, is launching fully insured and self-insured healthcare network options through Aetna Whole Health Atlanta.
A machine learning-powered smartphone application could help patients with a chronic cough document their symptoms over an extended period of time, according to new findings published in Digital Biomarkers.
An AI-powered wearable sensor can detect changes in heart failure patients before an actual crisis occurs, according to new findings published in Circulation: Heart Failure.
As AI continues to make a profound impact on the medical imaging industry, the FDA is hosting a two-day public workshop to discuss the benefits and risks of this powerful technology.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.